Ruth Gutiérrez-Aguilar

Dr. Ruth Gutiérrez-Aguilar

Facultad de Medicina, División de Investigación., Universidad Nacional Autónoma de México, Mexico City, Ciudad de México, Mexico
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
MFMaría Teresa Flores-Dorantes
María Teresa Flores-Dorantes
YDYael Efren Díaz-López
Yael Efren Díaz-López
RGRuth Gutiérrez-Aguilar
Ruth Gutiérrez-Aguilar
Obesity is a multifactorial disease in which environmental conditions and several genes play an important role in the development of this disease. Obesity is associated with neurodegenerative diseases (Alzheimer, Parkinson, and Huntington diseases) and with neurodevelopmental diseases (autism disorder, schizophrenia, and fragile X syndrome). Some of the environmental conditions that lead to obesity are physical activity, alcohol consumption, socioeconomic status, parent feeding behavior, and diet. Interestingly, some of these environmental conditions are shared with neurodegenerative and neurodevelopmental diseases. Obesity impairs neurodevelopment abilities as memory and fine-motor skills. Moreover, maternal obesity affects the cognitive function and mental health of the offspring. The common biological mechanisms involved in obesity and neurodegenerative/neurodevelopmental diseases are insulin resistance, pro-inflammatory cytokines, and oxidative damage, among others, leading to impaired brain development or cell death. Obesogenic environmental conditions are not the only factors that influence neurodegenerative and neurodevelopmental diseases. In fact, several genes implicated in the leptin–melanocortin pathway (LEP, LEPR, POMC, BDNF, MC4R, PCSK1, SIM1, BDNF, TrkB, etc.) are associated with obesity and neurodegenerative and neurodevelopmental diseases. Moreover, in the last decades, the discovery of new genes associated with obesity (FTO, NRXN3, NPC1, NEGR1, MTCH2, GNPDA2, among others) and with neurodegenerative or neurodevelopmental diseases (APOE, CD38, SIRT1, TNFα, PAI-1, TREM2, SYT4, FMR1, TET3, among others) had opened new pathways to comprehend the common mechanisms involved in these diseases. In conclusion, the obesogenic environmental conditions, the genes, and the interaction gene–environment would lead to a better understanding of the etiology of these diseases.

17 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SMSofia Moran-Ramos
Sofia Moran-Ramos
EOElvira Ocampo-Medina
Elvira Ocampo-Medina
RGRuth Gutiérrez-Aguilar
Ruth Gutiérrez-Aguilar
LMLuis Rodrigo Macias
Luis Rodrigo Macias
HVHugo Villamil-Ramírez
Hugo Villamil-Ramírez
SCSamuel Canizales-Quinteros
Samuel Canizales-Quinteros
Childhood obesity is associated with a number of metabolic abnormalities leading to increased cardiovascular risk. Metabolites can be useful as early biomarkers and new targets to promote early intervention beginning in school age. Thus, we aimed to identify metabolomic profiles associated with obesity and obesity-related metabolic traits. We used data from the Obesity Research Study for Mexican children (ORSMEC) in Mexico City and included a case control (n = 1120), cross-sectional (n = 554) and a longitudinal study (n = 301) of 6–12-year-old children. Forty-two metabolites were measured using electrospray MS/MS and multivariate regression models were used to test associations of metabolomic profiles with anthropometric, clinical and biochemical parameters. Principal component analysis showed a serum amino acid signature composed of arginine, leucine/isoleucine, phenylalanine, tyrosine, valine and proline significantly associated with obesity (OR = 1.57; 95%CI 1.45–1.69,P = 3.84 × 10−31) and serum triglycerides (TG) (β = 0.067,P = 4.5 × 10−21). These associations were validated in the cross-sectional study (P < 0.0001). In the longitudinal cohort, the amino acid signature was associated with serum TG and with the risk of hypertriglyceridemia after 2 years (OR = 1.19; 95%CI 1.03-1.39,P = 0.016). This study shows that an amino acid signature significantly associated with childhood obesity, is an independent risk factor of future hypertriglyceridemia in children.

6 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
NBNadejda Bozadjieva-Kramer
Nadejda Bozadjieva-Kramer
JSJae Hoon Shin
Jae Hoon Shin
YSYikai Shao
Yikai Shao
RGRuth Gutiérrez-Aguilar
Ruth Gutiérrez-Aguilar
ZLZiru Li
Ziru Li
RSRandy J. Seeley
Randy J. Seeley
Bariatric surgeries such as the Vertical Sleeve Gastrectomy (VSG) are invasive but provide the most effective improvements in obesity and Type 2 diabetes. We hypothesized a potential role for the gut hormone Fibroblast-Growth Factor 15/19 which is increased after VSG and pharmacologically can improve energy homeostasis and glucose handling. We generated intestinal-specific FGF15 knockout (FGF15INT-KO) mice which were maintained on high-fat diet. FGF15INT-KO mice lost more weight after VSG as a result of increased lean tissue loss. FGF15INT-KO mice also lost more bone density and bone marrow adipose tissue after VSG. The effect of VSG to improve glucose tolerance was also absent in FGF15INT-KO. VSG resulted in increased plasma bile acid levels but were considerably higher in VSG-FGF15INT-KO mice. These data point to an important role after VSG for intestinal FGF15 to protect the organism from deleterious effects of VSG potentially by limiting the increase in circulating bile acids.

18 February 2020 in Boletín Médico del Hospital Infantil de México
Verified
Journal Article
Closed access
MFMaría E. Frigolet
María E. Frigolet
KDKim Dong-Hoon
Kim Dong-Hoon
SCSamuel Canizales-Quinteros
Samuel Canizales-Quinteros
RGRuth Gutiérrez-Aguilar
Ruth Gutiérrez-Aguilar
Obesity prevalence has increased in the last decades worldwide leading to metabolic complications, such as type 2 diabetes, steatosis, cardiovascular disease, among others; its development is influenced by genetic factors and environmental factors, such as intestinal microbiome. In Mexico, 33.3% of the adults present this disease. Obesity is defined as an excessive adipose tissue accumulation, provoking its dysfunction. Adipose tissue remodeling, which involves angiogenesis, hypoxia and inflammation, is implicated in the developing of obesity and metabolic modifications. Bariatric surgery is the most used and successful intervention to control morbid obesity, leading a maintained loss of weight and remission of some of its comorbidities as type 2 diabetes. Here, we review some of the molecular aspects of the metabolic changes provoked by bariatric surgery and its impact in weight loss and comorbidities remission. In summary, this article reviews the genetic aspects, microbiome and molecular facts (adipose tissue remodeling) that are involved in obesity development. In addition, some of the molecular aspects about bariatric surgery are described and the mechanisms that are regulated to control obesity and its comorbidities.

27 September 2017 in Revista Digital Universitaria
Verified
Journal Article
Open access
MFMaria E. Frigolet
Maria E. Frigolet
HGHospital Infantil de México “Federico Gómez”
Hospital Infantil de México “Federico Gómez”
RGRuth Gutiérrez-Aguilar
Ruth Gutiérrez-Aguilar
FMFacultad de Medicina Universidad Nacional Autónoma de México
Facultad de Medicina Universidad Nacional Autónoma de México
Las “ómicas” son las ciencias que permiten estudiar un gran número de moléculas, implicadas en el funcionamiento de un organismo. En las últimas décadas, el avance tecnológico ha permitido el estudio a gran escala de muchos genes, proteínas y metabolitos, permitiendo la creación de la genómica, proteómica, metabolómica, entre otras. Cada una de estas áreas ha ayudado a un mejor entendimiento de la causa de ciertas enfermedades. Además, la aplicación del conocimiento sobre las “ómicas” a la clínica podrá utilizarse para hacer un diagnóstico más temprano o para prevenir el desarrollo de una enfermedad. Así, la medicina se podrá convertir en medicina personalizada, donde cada individuo llevará un tratamiento para una determinada enfermedad acorde a su información genética y a su medio ambiente. En este artículo se define a cada una de las “ómicas”, la metodología que se usa para su análisis y un ejemplo de su aplicación clínica.

1 December 2022 in Genes
Verified
Journal Article
Open access
PDF file
Itzel Guadalupe Salazar ValenciaItzel Guadalupe Salazar Valencia
Itzel Guadalupe Salazar Valencia
HVHugo Villamil-Ramírez
Hugo Villamil-Ramírez
FBFrancisco Barajas-Olmos
Francisco Barajas-Olmos
MGMartha Guevara-Cruz
Martha Guevara-Cruz
LMLuis Rodrigo Macias
Luis Rodrigo Macias
SCSamuel Canizales-Quinteros
Samuel Canizales-Quinteros
The loss of function melanocortin 4-receptor (MC4R) Ile269Asn mutation has been proposed as one of the most important genetic contributors to obesity in the Mexican population. However, whether patients bearing this mutation respond differently to weight loss treatments is unknown. We tested the association of this mutation with obesity in 1683 Mexican adults, and compared the response of mutation carriers and non-carriers to three different weight loss interventions: dietary restriction intervention, phentermine 30 mg/day treatment, and Roux-en-Y gastric bypass (RYGB) surgery. The Ile269Asn mutation was associated with obesity [OR = 3.8, 95% CI (1.5–9.7), p = 0.005]. Regarding interventions, in the dietary restriction group only two patients were MC4R Ile269Asn mutation carriers. After 1 month of treatment, both mutation carriers lost weight: −4.0 kg (−2.9%) in patient 1, and −1.8 kg (−1.5%) in patient 2; similar to the mean weight loss observed in six non-carrier subjects (−2.9 kg; −2.8%). Phentermine treatment produced similar weight loss in six carriers (−12.7 kg; 15.5%) and 18 non-carriers (−11.3 kg; 13.6%) after 6 months of pharmacological treatment. RYGB also caused similar weight loss in seven carriers (29.9%) and 24 non-carriers (27.8%), 6 months after surgery. Our findings suggest that while the presence of a single MC4R loss of function Ile269Asn allele significantly increases obesity risk, the presence of at least one functional MC4R allele seems sufficient to allow short-term weight loss in response to dietary restriction, phentermine and RYGB. Thus, these three different interventions may be useful for the short-term treatment of obesity in MC4R Ile269Asn mutation carriers.